CPT® Code 83015 is used to report a screening test for heavy metals in biological specimens. This screening evaluates exposure to potentially toxic metals such as lead, mercury, arsenic, or cadmium, helping identify patients at risk for toxicity or environmental exposure.
This code represents a screening panel or initial assessment, not necessarily the definitive quantitative measurement of each individual metal, which may be reported with more specific codes when performed.
Key Facts About CPT® 83015
- Service type: Laboratory test (toxicology screening)
- Test: Heavy metal screen
- Specimen type: Blood, urine, or other biological samples
- Test purpose: Detect potential exposure to toxic metals
- Provider type: Laboratories, physicians, and qualified healthcare professionals
Common clinical indications:
- Suspected environmental or occupational exposure
- Evaluation of unexplained neurologic or systemic symptoms
- Monitoring patients at risk for heavy metal toxicity
- Preventive or integrative health screening
- Follow-up to abnormal or borderline screening results
When to Use CPT® 83015
CPT 83015 is appropriate when:
- Performing a screening evaluation for heavy metal exposure
- Assessing patients with possible toxic exposure
- Evaluating symptoms consistent with metal toxicity
- Conducting baseline or preventive toxicology screening
Examples:
- Screening a patient with suspected occupational exposure to heavy metals
- Evaluating unexplained fatigue, neurologic symptoms, or GI issues
- Performing baseline testing in patients with environmental exposure concerns
- Following up on potential toxic exposures identified in history
Documentation Requirements
To support CPT 83015 billing, documentation should include:
- Patient identifiers and date of service
- Clinical indication for screening
- Specimen type (e.g., blood, urine)
- Test performed (heavy metal screen)
- Results and date reported
- Ordering provider information
Clear documentation supports medical necessity and appropriate test utilization.
Reimbursement and Coding Considerations
- CPT 83015 may have variable coverage, especially for screening purposes
- Diagnosis coding should support suspected exposure or clinical symptoms
- Additional confirmatory or quantitative tests may be billed separately
- Payers may require documentation of medical necessity beyond routine screening
- Frequency of testing may be limited by payer policy
Always verify payer-specific toxicology and screening guidelines.
How OptiMantra Supports Toxicology Testing
OptiMantra’s integrated EMR and practice management platform streamlines documentation and billing for CPT 83015:
With OptiMantra, providers can:
- Order heavy metal screening tests within the patient chart
- Track results and follow-up testing over time
- Link lab findings to symptoms, exposure history, and care plans
- Maintain organized laboratory documentation that supports billing compliance and audit preparedness
- Integrate toxicology workflows into a single, efficient system
By centralizing lab and screening workflows, OptiMantra helps practices improve efficiency, ensure compliance, and optimize reimbursement.
Try OptiMantra for free here!
Disclaimer: CPT® codes are maintained by the American Medical Association. This guide is for informational purposes only and does not replace official coding guidelines or payer policies.
.png)
